Nuvectis Pharma, Inc.
Nuvectis Pharma is a clinical-stage biopharmaceutical company developing complement Factor B inhibitors and oncology candidates.
8-KAug 21Latest SEC filing, period to Jul 20
Aug 25Latest story
Nuvectis Pharma is a clinical-stage biopharmaceutical company developing complement Factor B inhibitors and oncology candidates.